The Efficacy and Influence Factors of Atorvastatin on Very Low Density Lipoprotein Cholesterol (VLDL-C) among Patients with High Risk of Coronary Heart Disease (CHD) in China
机构：[1]Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing, China临床科室心脏内科中心首都医科大学附属安贞医院
第一作者机构：[1]Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing, China
推荐引用方式(GB/T 7714)：
Zheng Qin,Mingjie Fu,Yujie Zhou.The Efficacy and Influence Factors of Atorvastatin on Very Low Density Lipoprotein Cholesterol (VLDL-C) among Patients with High Risk of Coronary Heart Disease (CHD) in China[J].JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY.2018,72(16):C175-C175.doi:10.1016/j.jacc.2018.08.782.
APA：
Zheng Qin,Mingjie Fu&Yujie Zhou.(2018).The Efficacy and Influence Factors of Atorvastatin on Very Low Density Lipoprotein Cholesterol (VLDL-C) among Patients with High Risk of Coronary Heart Disease (CHD) in China.JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY,72,(16)
MLA：
Zheng Qin,et al."The Efficacy and Influence Factors of Atorvastatin on Very Low Density Lipoprotein Cholesterol (VLDL-C) among Patients with High Risk of Coronary Heart Disease (CHD) in China".JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 72..16(2018):C175-C175
医学